logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Breast cancer: comparable efficacy, better safety with shorter trastuzumab duration

Shorter duration of trastuzumab may be preferable for patients at cardiotoxicity risk.